Aseptically Prepared Cytotoxic Medicines and Monoclonal Antibodies - North of England of
Estimated value
£40.7m
Awarded value
£40.7m
Awarded 18 Mar 2021
Suppliers
1
Lots
1
1 awarded
Published
29 Apr 2021
Deadline 25 Nov 2020
Description
National Framework Agreement for the supply of Aseptically Prepared Cytotoxic Medicines and Monoclonal Antibodies - North of England
Scope
- Reference
- CF-0189500D0O000000rwimUAA1
- Total value
- £40,700,000 excluding VAT
- Commercial tool
- Standalone contract
- Contract dates
- 31 Mar 2021 to 30 Mar 2022
- CPV classifications
- 33600000
- Particular suitability
- Small and medium-sized enterprises (SME)
Submission & procedure
- Submission deadline
- 25 Nov 2020, 1:00 pm
Award details
Awarded supplier(s), contract period and value as published in the award notice.
Awarded value
£40.7m
Award date
18 Mar 2021
Contract start
31 Mar 2021
Contract end
30 Mar 2022